These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15112301)

  • 1. A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas.
    Haroon HA; Buckley DL; Patankar TA; Dow GR; Rutherford SA; Balériaux D; Jackson A
    J Magn Reson Imaging; 2004 May; 19(5):527-36. PubMed ID: 15112301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
    Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
    J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
    Jain R; Narang J; Gutierrez J; Schultz LR; Scarpace L; Rosenblum M; Mikkelsen T; Rock JP
    Acad Radiol; 2011 Aug; 18(8):955-62. PubMed ID: 21718954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas.
    Lee MC; Cha S; Chang SM; Nelson SJ
    J Magn Reson Imaging; 2006 Mar; 23(3):257-66. PubMed ID: 16456821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI.
    Cheng HL
    J Magn Reson Imaging; 2008 Sep; 28(3):736-43. PubMed ID: 18777534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between dynamic contrast-enhanced MRI and expression of microvascular density in the glioma].
    Yin D; Wang XY; Yan XB; Liao WH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):686-9. PubMed ID: 16708810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.
    Ewing JR; Brown SL; Lu M; Panda S; Ding G; Knight RA; Cao Y; Jiang Q; Nagaraja TN; Churchman JL; Fenstermacher JD
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):310-20. PubMed ID: 16079791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
    Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
    J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases.
    Lee MC; Cha S; Chang SM; Nelson SJ
    J Magn Reson Imaging; 2005 Jun; 21(6):683-93. PubMed ID: 15906330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach.
    Cheng HL
    J Magn Reson Imaging; 2009 Oct; 30(4):864-72. PubMed ID: 19787732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.